Hormone Replacement Therapy Archives - Page 5 of 11

Increase in HDL-C, Adiponectin Levels With Glucocorticoid Replacement Therapy

By

Amit Akirov, MD

July 30, 2019

Glucocorticoid replacement therapy is associated with an increase in serum levels of adiponectin and high-density lipoprotein cholesterol.

Androgen and Reproductive Disorders

Testosterone Replacement in Congenital Hypogonadotropic Hypogonadism Has Limited Effects on Bone Health

By

Tyler Rice

April 2, 2019

Testosterone replacement therapy prevents further bone loss at the lumbar and femoral levels in patients with congenital hypogonadotropic hypogonadism, but it does not reliably elevate bone mineral density out of the osteopenic/osteoporotic range.

Androgen and Reproductive Disorders

Hormone Replacement Therapy May Increase Risk for Alzheimer Disease

By

Amit Akirov, MD

March 13, 2019

Long-term use of systemic hormone replacement therapy may slightly increase the risk of developing Alzheimer disease.

General Endocrinology

Type of Estrogen Therapy Used Has an Impact on Adult Outcomes in Turner Syndrome

By

Roxanne Nelson, BSN, RN

February 21, 2019

An earlier age of onset of puberty may be beneficial for adult bone density in Turner syndrome and type of hormone therapy may have a varying impact on adult health.

Androgen and Reproductive Disorders

Impact of Women’s Health Initiative on Menopausal Hormone Therapy Trends

By

Rita Aghjayan

January 29, 2019

Initiation and continuation trends in menopausal hormone therapy may have been influenced by the premature cessation of the 2002 Women’s Health Initiative trial, which was halted due to safety concerns.

Androgen and Reproductive Disorders

Hormone Therapy Linked to Reduced Symptomatic Knee OA in Postmenopausal Women

By

Endocrinology Advisor Contributing Writer

January 25, 2019

Hormone therapy in postmenopausal women may be protective against knee OA.

Androgen and Reproductive Disorders

Higher Risk for Venous Thromboembolism With Oral vs Transdermal HRT

By

Rachael Beairsto

January 9, 2019

Oral preparations of hormone replacement therapy for the treatment of menopausal symptoms are associated with a greater risk for VTE compared with transdermal formulations.

Practice Management

Better Training Needed to Boost LGBTQ Patient Health Care

September 14, 2018

High-quality health care needs to be provided to lesbian, gay, bisexual, transgender, and queer (LGBTQ) patients, and improved training is necessary to deliver that care.